Zoetis (ZTS) Total Current Liabilities (2012 - 2026)

Zoetis' (ZTS) quarterly Total Current Liabilities came in at $2.1 billion in Q1 2026, down 39.35% year-on-year from $3.4 billion in Q1 2025, and down 5.52% on a QoQ basis from $2.2 billion in Q4 2025.

Zoetis (ZTS) Total Current Liabilities (2012 - 2026) Analysis & Trends

Zoetis (ZTS) has 15 years of Total Current Liabilities data on file, last reported at $2.1 billion in Q1 2026.

  • On a quarterly basis, Total Current Liabilities fell 39.35% year-over-year to $2.1 billion in Q1 2026; TTM through Mar 2026 was $2.1 billion, a 39.35% decrease from a year earlier, with the FY2025 full-year figure at $2.2 billion, down 36.31% from the prior year.
  • Total Current Liabilities for Q1 2026 stood at $2.1 billion, down from $2.2 billion in the prior quarter.
  • Over the last five years, Total Current Liabilities for ZTS reached as high as $3.4 billion in Q4 2024 and fell as low as $1.6 billion in Q3 2023.
  • Historically, Total Current Liabilities has averaged $2.4 billion across 5 years, with a median of $2.1 billion in 2026.
  • Across the five-year window, Total Current Liabilities jumped 95.79% in 2022 and sank 44.17% in 2023, its largest moves.
  • Year by year, Total Current Liabilities stood at $3.2 billion in 2022, then slumped by 40.35% to $1.9 billion in 2023, then jumped by 80.62% to $3.4 billion in 2024, then sank by 36.31% to $2.2 billion in 2025, then dropped by 5.52% to $2.1 billion in 2026.
  • Per Business Quant data, the three most recent Total Current Liabilities figures were $2.1 billion in Q1 2026, $2.2 billion in Q4 2025, and $1.8 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 6.56 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 13.53 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 2.05 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 18.06 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 599.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 13.17 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 6.81 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 831.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 1.66 Bn
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn 215.80 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.05 Bn
Dec 31, 2025 2.17 Bn
Sep 30, 2025 1.81 Bn
Jun 30, 2025 3.37 Bn
Mar 31, 2025 3.39 Bn
Dec 31, 2024 3.41 Bn
Sep 30, 2024 1.70 Bn
Jun 30, 2024 1.80 Bn
Mar 31, 2024 1.91 Bn
Dec 31, 2023 1.89 Bn
Sep 30, 2023 1.61 Bn
Jun 30, 2023 1.77 Bn
Mar 31, 2023 1.92 Bn
Dec 31, 2022 3.17 Bn
Sep 30, 2022 2.88 Bn
Jun 30, 2022 3.05 Bn
Mar 31, 2022 3.03 Bn
Dec 31, 2021 1.80 Bn
Sep 30, 2021 1.47 Bn
Jun 30, 2021 2.09 Bn